Last reviewed · How we verify

Oxygen 40 % — Competitive Intelligence Brief

Oxygen 40 % (Oxygen 40 %) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Medical gas / Respiratory therapeutic. Area: Respiratory / Critical Care.

marketed Medical gas / Respiratory therapeutic Respiratory / Critical Care Small molecule Live · refreshed every 30 min

Target snapshot

Oxygen 40 % (Oxygen 40 %) — George Papanicolaou Hospital. Oxygen at 40% concentration increases the partial pressure of oxygen in the blood to improve tissue oxygenation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Oxygen 40 % TARGET Oxygen 40 % George Papanicolaou Hospital marketed Medical gas / Respiratory therapeutic

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Medical gas / Respiratory therapeutic class)

  1. George Papanicolaou Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Oxygen 40 % — Competitive Intelligence Brief. https://druglandscape.com/ci/oxygen-40. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: